首页> 外文期刊>Journal of Hainan Medical University >Effects of Digoxin and Tongxinluo capsule combination treatment on oxidative stress, cytokines and vascular endothelial function in patients with chronic heart failure
【24h】

Effects of Digoxin and Tongxinluo capsule combination treatment on oxidative stress, cytokines and vascular endothelial function in patients with chronic heart failure

机译:地高辛和通心络胶囊联合治疗对慢性心力衰竭患者氧化应激,细胞因子和血管内皮功能的影响

获取原文
       

摘要

Objective: To explore the effect of digoxin and Tongxin capsule combined therapy onoxidative stress, cytokines and vascular endothelial function in patients with chronic heartfailure, and provide help for clinical treatment of patients with chronic heart failure. Methods:95 cases of chronic heart failure in our hospital were randomly divided into observation group(47 cases) and control group (48 cases). Control group patients were given basic treatment, andobservation group received combination therapy of digoxin and Tongxinluo capsule, to detectand to investigate the changes of oxidative stress, cytokines and vascular endothelial function intwo groups of patients before and after treatment. Results: There was no significant differencein oxidative stress, cytokines and vascular endothelial function between the two groups ofchronic heart failure patients before treatment (P0.05). Compared with before treatment, themalondialdehyde (MDA) and cytokines [tumor necrosis factor-α (TNF-α), C-reactive protein(CRP), interleukin-6 (IL-6) and brain natriuretic peptide (BNP)] in two groups of patients withchronic heart failure after treatment decreased significantly (P0.05), while indexes relatedto endothelial function [hyperemic brachial artery diameter after reactive hyperemia, brachialartery diameter change rate, brachial artery endothelial dependent diastolic function (FMD),and brachial artery endothelium dependent diastolic function (NMD)] and related indexes ofoxidative stress [glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and catalase(CAT)] were significantly increased (P0.05). The related indexes and oxidative stress indexes(GSH-Px, CAT and SOD) of observation group after the combined treatment in patients withendothelial function were significantly higher than the control group after treatment (P0.05).After treatment, cytokines and MDA levels were significantly lower than the control group(P0.05). Conclusions: Tongxinluo capsule combined with digoxin treatment significantlyimproved the oxidative stress, cytokines and vascular endothelial function levels in patientswith chronic heart failure, and has important clinical significance for the treatment of patientswith chronic heart failure.
机译:目的:探讨地高辛和通心胶囊联合治疗对慢性心力衰竭患者氧化应激,细胞因子和血管内皮功能的影响,为慢性心力衰竭患者的临床治疗提供帮助。方法:将我院95例慢性心力衰竭患者随机分为观察组(47例)和对照组(48例)。对照组患者接受基础治疗,观察组采用地高辛和通心络胶囊联合治疗,以检测和研究两组患者治疗前后的氧化应激,细胞因子和血管内皮功能的变化。结果:两组慢性心力衰竭患者治疗前的氧化应激,细胞因子和血管内皮功能无明显差异(P> 0.05)。与治疗前比较,两组患者的丙二醛(MDA)和细胞因子[肿瘤坏死因子-α(TNF-α),C反应蛋白(CRP),白细胞介素-6(IL-6)和脑钠肽(BNP)]慢性心力衰竭患者治疗后的比例显着降低(P <0.05),而与内皮功能有关的指标[反应性充血后的肱动脉血径,肱动脉直径变化率,肱动脉内皮依赖性舒张功能(FMD)和肱动脉内皮依赖性舒张功能功能(NMD)]和氧化应激的相关指标[谷胱甘肽过氧化物酶(GSH-Px),超氧化物歧化酶(SOD)和过氧化氢酶(CAT)]显着增加(P <0.05)。内皮功能患者联合治疗后观察组的相关指标和氧化应激指标(GSH-Px,CAT和SOD)明显高于对照组(P <0.05)。治疗后,细胞因子和MDA水平明显低于对照组(P <0.05)。结论:通心络胶囊联合地高辛治疗可显着改善慢性心力衰竭患者的氧化应激,细胞因子和血管内皮功能水平,对慢性心力衰竭患者具有重要的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号